Green synthesis of silver nanoparticles for the targeted delivery to HER2-overexpressing cancer cells

被引：0

作者：

Shipunova, V. ^{[1
,2
]}

Belova, M. ^{[3
]}

Komedchikova, E. ^{[1
]}

Babenyshev, A. ^{[4
]}

Deyev, S. ^{[1
,2
]}

机构：

[1] RAS, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia

[2] Natl Res Nucl Univ MEPhI, Moscow, Russia

[3] Russian State Agr Univ, Moscow Timiryazev Agr Acad, Moscow, Russia

[4] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia

来源：

FEBS OPEN BIO | 2019年 / 9卷

基金：

俄罗斯科学基金会;

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

P-36-035

引用

页码：381 / 381

页数：1

共 50 条

[31] HER2 down-modulation increases sensitivity to trastuzumab in HER2-overexpressing breast cancer cells
Valabrega, Giorgio
Montemurro, Filippo
Aglietta, Massimo
Giordano, Silvia
ANNALS OF ONCOLOGY, 2005, 16 : 30 - 30
[32] Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates
Savellano, MD
Pogue, BW
Hoopes, PJ
Vitetta, ES
Paulsen, KD
CANCER RESEARCH, 2005, 65 (14) : 6371 - 6379
[33] Activity of lapatinib is independent of EGFR expression level in HER2-overexpressing breast cancer cells
Zhang, Dongwei
Pal, Ashutosh
Bornmann, William G.
Yamasaki, Fumiyuki
Esteva, Francisco J.
Hortobagyi, Gabriel N.
Bartholomeusz, Chandra
Ueno, Naoto T.
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (07) : 1846 - 1850
[34] Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
Clara Natoli
Patrizia Vici
Isabella Sperduti
Antonino Grassadonia
Giancarlo Bisagni
Nicola Tinari
Andrea Michelotti
Germano Zampa
Stefania Gori
Luca Moscetti
Michele De Tursi
Michele Panebianco
Maria Mauri
Ilaria Ferrarini
Laura Pizzuti
Corrado Ficorella
Riccardo Samaritani
Lucia Mentuccia
Stefano Iacobelli
Teresa Gamucci
Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1229 - 1240
[35] Prognostic Value of Basal Phenotype in HER2-overexpressing Breast Cancer
Sanjay P. Bagaria
Partha S. Ray
Jinhua Wang
Luisa Kropcho
Alice Chung
Myung-Shin Sim
Jaime M. Shamonki
Silvana Martino
Xiaojiang Cui
Armando E. Giuliano
Annals of Surgical Oncology, 2012, 19 : 935 - 940
[36] Self-assembling nanoparticles biofunctionalized with magnetite-binding protein for the targeted delivery to HER2/neu overexpressing cancer cells
Shipunova, Victoria O.
Kotelnikova, Polina A.
Aghayeva, Ulkar F.
Stremovskiy, Oleg A.
Novikov, Ilya A.
Schulga, Alexey A.
Nikitin, Maxim P.
Deyev, Sergey M.
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2019, 469 : 450 - 455
[37] HER2-overexpressing breast cancer: time for the cure with less chemotherapy?
Loi, Sherene
de Azambuja, Evandro
Pugliano, Lina
Sotiriou, Christos
Piccart, Martine J.
CURRENT OPINION IN ONCOLOGY, 2011, 23 (06) : 547 - 558
[38] Prognostic Value of Basal Phenotype in HER2-overexpressing Breast Cancer
Bagaria, Sanjay P.
Ray, Partha S.
Wang, Jinhua
Kropcho, Luisa
Chung, Alice
Sim, Myung-Shin
Shamonki, Jaime M.
Martino, Silvana
Cui, Xiaojiang
Giuliano, Armando E.
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (03) : 935 - 940
[39] Effect of Oncoxin Oral Solution in HER2-Overexpressing Breast Cancer
Hernandez-Garcia, Susana
Gonzalez, Verena
Sanz, Eduardo
Pandiella, Atanasio
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2015, 67 (07): : 1159 - 1169
[40] Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
Natoli, Clara
Vici, Patrizia
Sperduti, Isabella
Grassadonia, Antonino
Bisagni, Giancarlo
Tinari, Nicola
Michelotti, Andrea
Zampa, Germano
Gori, Stefania
Moscetti, Luca
De Tursi, Michele
Panebianco, Michele
Mauri, Maria
Ferrarini, Ilaria
Pizzuti, Laura
Ficorella, Corrado
Samaritani, Riccardo
Mentuccia, Lucia
Iacobelli, Stefano
Gamucci, Teresa
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (07) : 1229 - 1240

← 1 2 3 4 5 →